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ABSTRACT The desire to understand tumor complexity has given rise to mathematical models to describe the tumor micro-
environment. We present a new mathematical model for avascular tumor growth and development that spans three distinct
scales. At the cellular level, a lattice Monte Carlo model describes cellular dynamics (proliferation, adhesion, and viability). At
the subcellular level, a Boolean network regulates the expression of proteins that control the cell cycle. At the extracellular level,
reaction-diffusion equations describe the chemical dynamics (nutrient, waste, growth promoter, and inhibitor concentrations).
Data from experiments with multicellular spheroids were used to determine the parameters of the simulations. Starting with a
single tumor cell, this model produces an avascular tumor that quantitatively mimics experimental measurements in multicellular
spheroids. Based on the simulations, we predict: 1), the microenvironmental conditions required for tumor cell survival; and 2),
growth promoters and inhibitors have diffusion coefﬁcients in the range between 106 and 107 cm2/h, corresponding to
molecules of size 80–90 kDa. Using the same parameters, the model also accurately predicts spheroid growth curves under
different external nutrient supply conditions.
INTRODUCTION
Primary malignant tumors are thought to arise from small
nodes of cells that have either lost, or ceased to respond to,
normal growth regulatory mechanisms, presumably through
mutations and/or altered gene expression (1,2). As the tumor
develops, this genetic instability causes continued malignant
alterations, including invasion, angiogenesis, and metastatic
spread, resulting in a large, biologically complex tumor.
However, essentially all tumors, both primary and metastatic,
go through a relatively simpler, avascular stage of growth,
with nutrient supply by diffusion from the surrounding tissue.
Before developing a blood supply, these tumors are not
capable of acquiring sufﬁcient nutrients to ensure continued
exponential growth of the tumor cell mass despite the con-
tinuous nutrient supply at the tumor surface. Thus, avascular
tumors undergo a quasi-exponential growth phase followed
by a saturation phase in which they maintain approximately
constant volume. The restricted supply of critical nutrients,
such as oxygen and glucose, results in marked gradients
within the cell mass. The tumor cells respond through induced
alterations in physiology and metabolism as well as through
altered gene and protein expression (3,4). In fact, many of the
later manifestations of malignancy, including invasion and
angiogenesis, are thought to be enhanced, if not precipitated,
by the stressful microenvironment that develops in the initial,
avascular tumor nodule. Consequently, a better understand-
ing of the regulation of the growth and malignant de-
velopment of avascular tumors would be beneﬁcial; insights
in such systems would also be valuable in understanding the
heterogeneous microenvironments found within larger tu-
mors (5).
Multicellular tumor spheroids are a frequently used in
vitro model of avascular tumor growth and the microenvi-
ronmental and physiological perturbations that occur in
tumors (6,7). Spheroids are aggregates of tumor cells that can
be grown in precisely controlled external nutrient conditions,
and assays of spheroid parameters, such as volume, cell
number, viable and necrotic fractions, and saturation size, are
relatively easily obtained (8–10). Nutrient supply to spher-
oids is through diffusion from the surface. Thus, as the
aggregate grows, it develops nutrient-deprived inner regions.
Spheroids develop many of the hallmark features of avas-
cular tumors, including proliferation arrest, altered metabo-
lism, perturbed gene and protein expression, necrotic death,
and therapy resistance (3,6,7). In addition, spheroid growth
curves show the same kinetics as those of nodular tumors in
vivo, including quasi-exponential growth and saturation in
size (8,9,11).
A descriptive model (8) to explain the regulation of
growth and viability in spheroids postulates that, at early
stages of development, both growth promoters and viability
promoters can reach all of the cells in the spheroid. During
this early stage, the aggregate is composed of proliferating,
viable cells. As the spheroid grows, the concentration of
growth promoters decreases in the spheroid center, which
eventually falls below a critical value such that cells undergo
proliferation arrest and become quiescent. However, since
the spheroid continues to grow due to the outer proliferating
cells, the central concentration of viability promoters con-
tinues to decrease. Once the concentration of viability pro-
moters drops below a critical value, necrotic cell death
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occurs and the spheroids acquire a necrotic center. Continued
cellular metabolism and/or the process of necrosis cause
growth inhibitors and viability inhibitors to be secreted and
accumulate in the spheroid. When the concentration of growth
inhibitors reaches a critical value in the outer spheroid
region, cell proliferation is further reduced. When viability
inhibitors reach a critical value, they also contribute to the
expansion of the necrotic center. Eventually, the thickness of
the proliferating layer of cells is reduced to a point at which
the number of new cells is equal to the number of cells lost
by cell shedding, causing saturation in the spheroid growth.
Experimental data supports the idea that simple molecules
involved in energy metabolism, such as oxygen and glucose,
are the viability promoters in spheroids (8,9). There is also
some limited data indicating that growth inhibitors are small
protein factors (12). Currently, however, essentially nothing
is known about growth promoters or viability inhibitors in
this tumor model system, or in avascular tumors in vivo.
Recent molecular research with the spheroid system has
suggested that the factors regulating proliferation act through
signaling pathways, which are connected to the cyclin-cyclin
dependent kinase (CDK) cell-cycle regulatory mechanism.
The primary regulatorymechanism in this tumormodel seems
to be the induction of cyclin-dependent kinase inhibitors
(CKIs). LaRue et al. (13) showed that a large upregulation of
the CKI p18 occurred in untransformed ﬁbroblasts cultured as
spheroids, which accounts for their arrest in the G1-phase and
inability to proliferate in aggregate culture. Transformed ﬁ-
broblasts did not show this upregulation of p18, and spheroids
of such cells are able to grow to large sizes. Recently, the same
group has demonstrated that the initial induction of G1-phase
arrest in large spheroids, presumably in response to some
microenvironmental gradient of growth promoters, is due to
the upregulation of two CKIs from different families, p18 and
p27, with little change in CDKs or other CKIs (14). As spher-
oids reach sizes near that of growth saturation, with a sizable
necrotic center, it was also shown that the innermost cells
downregulated all of their cell-cycle regulatory machinery,
including cyclins, CDKs, and CKIs (14). The latter result may
be due to cell exposure to a growth-inhibitory factor, or may
be the result of a prolonged period spent in a nutrient-stressed
state. In either case, these results demonstrate that prolif-
eration arrest in this avascular tumor model is controlled by
a protein regulatory network operating within the tumor cells.
A predictive model of avascular tumor growth has to
account for the complexity of these processes. Important ele-
ments that need to be incorporated in such a model include
cell proliferation and growth, nutrient consumption and dif-
fusion, waste product production and diffusion, effects of
growth promoting and inhibitory factors, intercellular adhe-
sion, and cell-environment interactions, as well as the geom-
etry of the tumor and the cells. Most of the existing models
for cellular dynamics in tumors are either simple empirical
mathematical expressions (11,15), rate equations of cell
populations (16–22), or cellular automaton models of inter-
acting cells, each occupying a single lattice site (23,24). The
only previous tumor model that included cell geometry was
able to reproduce a layered structure only by introducing an
artiﬁcial potential (25). A recent model that employs a hybrid
of cellular automata for cell representation and continuous
equations for chemical and blood ﬂow in a hexagonal grid of
blood vessels represents the state-of-the-art in tumor growth
modeling (26,27).
In this article, we present a multiscale cellular model to
describe the dynamics of avascular tumor growth and devel-
opment. At the cellular scale, ourmodel considers cell growth
and proliferation, intercellular adhesion, and necrotic cell
death. At the subcellular scale, we include a protein expres-
sion regulatory network for the control of cell-cycle arrest. At
the extracellular scale, the model considers diffusion, con-
sumption, and production of nutrients, metabolites, growth
promoters, and inhibitors. Data from experiments with
multicellular spheroidswere used to determine the parameters
for the simulations. Starting with a single tumor cell, this
model naturally evolves with time to produce an avascular
tumor that quantitatively mimics experimental measurements
in multicellular spheroids.
METHODS
Multicellular tumor spheroids
Multicellular tumor spheroids of the EMT6/Ro mouse mammary tumor cell
line were cultured in suspension as described in detail previously (8,10).
Spheroids were initiated from monolayer-cultured cells, which were har-
vested to generate a uniform-sized population containing 13 104 spheroids.
These spheroids were then placed into four large spinner ﬂasks ﬁtted with an
apparatus for supplying a controlled gas content and humidity, and were
replenished with fresh medium every 10–14 h. External concentrations of
oxygen and glucose were maintained within 5% of the initial value over
a range of concentrations from 0.08 to 0.28 mM oxygen and 1.6 to 16.5 mM
glucose (10). As shown in Fig. 1, the spheroids developed a spherically
FIGURE 1 Illustration of the morphology and proliferative status of cells
in multicellular spheroids of the EMT6/Ro cell line. (A) Histological cross-
section (optical microscopic image) through the center of a spheroid;1200
mm in diameter stained with eosin and hematoxalin, showing the viable rim
of cells (red) and the necrotic center (orange). (B) Diagram illustrating the
relative distributions of proliferating (green, P) and quiescent (red, Q) cells
and central necrosis (gray, N) in a spheroid, relative to the gradients in
nutrients and waste products. There is not actually a sharp demarcation
between proliferating and quiescent cells as is the case for viable/necrotic
boundary; rather, the fraction of proliferating cells decreases continuously
across the viable cell rim.
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symmetric distribution of proliferating and quiescent cells surrounding a
necrotic core.
For spheroids,400–500 mm in diameter, sampling was done by remov-
ing a volume of the well-mixed spheroid suspension. For measuring the
population mean diameter, a 10-ml sample was removed immediately after
medium change, assayed, and replaced into the ﬂask. For measuring the
number of cells per spheroid, 100 ml of the medium containing the spheroids
were removed at the time of medium change every 48 h, dissociated into
single cells, and assayed. For larger spheroids, sampling is done by collecting
the spheroids that settle in the ﬂask and manually removing the desired
number of spheroids. Spheroids were processed for histology after ﬁxation in
10% buffered formalin using standard techniques, and 5-mm-thick sections
were stainedwith eosin and hematoxalin to distinguish the viable and necrotic
regions (9,10). Parametersmeasured in previous studieswere used to calibrate
and reﬁne the simulation parameters. These parameters include: total spheroid
volume, number of cells per spheroid, cell-cycle phase distribution, and the
thickness of the viable cell rim (8,9). Previously published data on oxygen and
glucose consumption rates (28,29) and oxygen tension distributions within
spheroids (30) were also used in our simulations.
Multiscale cellular model
Our multiscale cellular model consists of three levels. At the cellular level,
a discrete lattice Monte Carlo model considers cell growth, proliferation,
death, and intercellular adhesion. At the subcellular level, a simpliﬁed
Boolean protein expression regulatory network controls cell-cycle arrest. At
the extracellular level, a system of differential equations describes diffusion,
consumption, and production of nutrients, metabolites, growth promoters,
and inhibitors. The three levels are closely integrated. We use model param-
eters derived from previous multicellular spheroid experiments.
Cellular model
The cellular model is based on the extended large-Q Potts model (31,32).
A simpler version of cellular and extracellular levels has been published
previously (32) and a model framework has been developed recently (33).
Brieﬂy, the discrete lattice Monte Carlo model partitions the three-dimen-
sional space into domains of cells and cell medium. Every cell is treated as
an individual entity with a unique ID number, which occupies all the lattice
sites within the cell domain (see, e.g., Fig. 2 in (32)). In this representation,
a cell has a ﬁnite volume and a deformable shape. A typical cell occupies 27
lattice sites. The extracellular matrix in the spheroids is neglected. Cells have
direct contact and interact with each other through surface adhesion and
competition for space. The interactions are characterized through a total
energy of
H ¼ +
lattice sites
JtðS1ÞtðS2Þ½1 dðS1; S2Þ1 +
cells
gðv VTÞ2: (1)
In the ﬁrst term, S is the cell ID, Jtt9 corresponds to the adhesive energy
between cell types t and t9, and d is the Kroneker d-function; this term
describes the total energy due to cell surface adhesion to each other.Cell-type-
dependent adhesion is based on the Differential Adhesion Hypothesis
(34,35). Different cell types may express different cell adhesion molecules or
a different number of cell adhesionmolecules on their surfaces, and thus have
different strengths of adhesivity; the differential adhesion hypothesis states
that the difference in cell adhesivity drives cell sorting into minimal surface
energy conﬁguration. In the second term, v and VT are the current and the
target volume of the cell, respectively, and g is the coefﬁcient corresponding
to the elasticity of the cell volume.Anydeviation from the target volume gives
rise to a volume energy, which keeps the cell volume close to the target
volume. Note that our cell type refers to the proliferating status of the cell:
proliferating, quiescent, or necrotic and medium, and not the tissue type.
Moreover, in our model, the different cell types only differ in their physical
properties (cell-cycle duration, metabolic rates, cell adhesion, and maximum
volume). External cell culture medium and the necrotic core are treated as
special cells. Medium does not have a target volume; thus, proliferating cells
can invade the external space when they grow. A necrotic cell, on the other
hand, has a target volume set to its current volume, and a large g-value
corresponding to a rigid body. Thus, its space cannot be invaded by the
growingmass of viable tumor cells. Every time a cell dies, its volume is added
to the target volume of the necrotic core. Our model does not consider
apoptosis; cell death means strictly necrosis in this article. This assumption is
based on the lack of any experimental data showing apoptosis in EMT6/Ro
spheroids, as well as the fact that the majority of cell death in the spheroids
occurs by necrosis (6). Spheroid experiments using other cell lines, e.g., Rat
1-T1 and MR1, have shown a low level of single cell death via apoptosis
occurring in the viable cell rim despite sufﬁcient nutrient availability (36).
This feature can be easily accommodated in ourmodel, althoughwe believe it
will have little impact on the overall spheroid dynamics.
This cellular model evolves by a standard Monte Carlo procedure. A
random lattice site is selected; the cell ID at this site is changed to the value
of one of its unlike neighbors’ ID. The probability for accepting such a
change is
p ¼ 1; DH, 0
e
DH
kbT; DH$ 0
;

(2)
where DH is the total energy difference due to such a change, and T is the
effective cell temperature, corresponding to the amplitude of cell membrane
ﬂuctuation (37). A Monte Carlo step (MCS) consists of as many trial lattice
updates as the total number of lattice sites. The cell system minimizes its
total energy. If there is no cell growth, division, or death, this model would
reproduce the cell conﬁguration that minimizes the total cell surface
adhesion energy (31).
We set the target volume to be twice the initial cell volume, so that the
cell grows in time until its volume reaches the target volume. Each cell also
carries a cell clock, which ticks to a maximum time corresponding to the
duration of a cell cycle. Only when the cell clock reaches the cell-cycle dura-
tion and the cell volume reaches the target volume will the cell decide to
divide. Cell division is simply reassigning half of the volume to a new cell
ID. The daughter cells inherit all properties of their parent.
Extracellular microenvironment
Cells also interact with their microenvironment, which is characterized by
local concentrations of biochemicals. The extracellular microenvironment
includes nutrients (oxygen and glucose), metabolic waste, growth pro-
moters, and inhibitors. Based on previous measurements with the EMT6 cell
line (28), we assume that most of the glucose consumed (75%) ﬂows through
the anaerobic glycolysis and produces lactate as waste, while a minority
(25%) ﬂows through the Krebbs cycle and respiration; oxygen consumption
is connected to glucose consumption through respiratory catabolism to
generate CO2, which rapidly diffuses away. Hence, we consider that the
main waste in the tumor is lactate, and that the lactate production rate is 1.5
times the glucose consumption rate.
In our model, oxygen and glucose are viability promoters, while lactate
is viability inhibitor. Our model considers generic growth and inhibitory
factors. Chemical reaction-diffusion is described by
@u
@t
¼ D=2u1 f ðx; y; zÞ: (3)
This is the generic equation for all chemicals in our model (detailed
equations are shown in Appendix): the chemical concentration u diffuses
with the diffusion coefﬁcient D and is produced (or consumed) at rate f.
The metabolic rate f depends on the individual cell’s state (proliferating,
quiescent, or necrotic); thus, it is a function of location.
We make a few further simplifying assumptions. In reality, a spheroid
consists of tumor cells, their extracellular matrix, and the necrotic core;
chemicals diffuse in the extracellular matrix, and bind and are internalized
(or generated and secreted) by the cells; chemicals also diffuse in the
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necrotic core with a different diffusion constant. As we do not include the
extracellular matrix explicitly in our cellular model, we assume that 1),
inside the spheroid the diffusion coefﬁcients are constant, neglecting the
differences of diffusion rates in extracellular matrix or cells or necrotic core;
and 2), each cell is chemically homogeneous, although different cells
might have different chemical concentrations. In the spheroid experiments,
oxygen, nutrients, and growth factors are supplied to the surface of the
spheroid via convection, and the cell medium is updated frequently such that
the chemical concentrations in the medium are kept constant. So we addi-
tionally assume that: 3), the cell-culture medium outside the spheroid main-
tains a constant level of metabolites; and 4), the external medium has no waste
or inhibitory factors in it. With these assumptions, we can solve the equations
on a much coarser lattice than the lattice for cells. More details are described
in the Appendix.
Cell cycle
The passage of a cell through its cell cycle is controlled by cytoplasmic
proteins, the main players of which include cyclins, CDKs, CKIs, and the
anaphase-promoting complex. Since experiments demonstrate that.85% of
the quiescent cells in spheroids are arrested in the G1-phase (9,14), in our
model, the cells in their G1-phase have the highest probability of becoming
quiescent. To realistically represent this cell-cycle arrest, we include a
simpliﬁed protein regulatory network to control the transition between the
G1- and S-phases. If the cell passes the G1-S transition checkpoint, it will
most likely proceed toward mitosis (or division). Arrest of cells in the S- and
G2-phases has been documented in spheroids of some cell lines, but not others
(14); however, the number of such cells in a spheroid is relatively small.
Our simpliﬁed protein regulatory network, shown in Fig. 2, is based on
the cell-cycle protein regulatory network for Homo sapiens from the Kyoto
Encyclopedia of Genes and Genomes (http://www.kegg.com/). We include
the following list of proteins: GSK3b, TGFb, SMAD3, SMAD4, SCF, CDK
inhibitors 4a–d (p15, p16, p18, p19), Kip 1,2 (p27, p57), Cip1 (p21), cyclins
D and E, Rb, and E2F. We ignore a few other proteins, such as Cyclin A,
from the network because they do not inﬂuence the outcome of our network.
The proteins we selected come into play at different stages of the G1-phase
and their inﬂuence differs in duration. For simplicity, we combine the groups
of proteins whose expressions have the same effect on the ﬁnal outcome of
the network. Thus, p15 in Fig. 2 stands for p15, p16, p18, and p19 (the whole
group of CDK inhibitors 4a–d), and p27 includes p57 expression as well. In
our model, these proteins can have only two levels of expression—on and
off. If the link pointing to a protein ends with an arrow, it means the link is
stimulatory; if the link ends with a bar, it means the link is prohibitory.
This network of proteins is designed to favor the cell transition from
G1- to S-phase. However, concentrations of the growth and inhibitory
factors directly inﬂuence the protein expression, and thus the cell prolifera-
tion state. At every time step, we calculate a local factor level of
Factor level ¼ 11 ea gFihFinitGF uð Þ
 1
; (4)
where gF and ihF are current local concentrations of growth and inhibitory
factors, respectively—in which both are outputs of the extracellular
chemical equations; initGF is the concentration of growth factors in the
medium surrounding the aggregate; u is a factor level threshold; and a is
a free parameter. If the factor level is above the threshold, the protein is
turned on under two circumstances: if all the links pointing to it are
stimulatory and all the proteins at the beginning of the links are on; or if all
the links are prohibitory and the proteins at the beginning of the links are off.
All other situations would turn off the protein. If the factor level is below the
threshold, this factor level is the probability that a protein will be turned on
or off—the higher the factor level (as a result of high growth factor level and
low inhibitory factor level), the higher the probability of protein being turned
on or off. If the outcome of this Boolean regulatory network is zero, i.e.,
protein E2F is off, the cell undergoes cell-cycle arrest or turns quiescent.
Otherwise, it continues its transit through the cell cycle.
Simulation
The integration of these three parts of the model is illustrated in the ﬂow
chart (Fig. 3). The tumor growth starts from a single tumor cell in the center
of the lattice with its ﬁrst set of proteins turned on (top tier in Fig. 2). Cell
growth and division follow the cell cycle, which we divide into 16 stages.
According to their respective durations, we assign G1-phase to consist of six
stages, S-phase of six stages, and G2- and M-phases of four stages com-
bined. Hence the whole cell-cycle duration, which is ;12 h in an expo-
nentially growing monolayer culture, is equivalent to 16 stages. In our
model, cells typically double their volume in four Monte Carlo steps (MCS).
So each cell-cycle stage corresponds to 1/4 MCS or ;3/4 h.
During each iteration, we ﬁrst evolve the cell lattice for 1/4 MCS, then
solve chemical reaction diffusion equations for 3/4 h to obtain the
concentrations of metabolites for each cell. For cells during G1-phase, the
local factor levels change the expressions of proteins in the regulatory
network. The cell then reacts to its local environment in the following steps.
First, it checks the local chemical environment: a proliferating cell decides
whether to proceed to the next stage of the cell cycle or become quiescent,
while a quiescent cell decides whether to become necrotic because of hostile
environment. Second, it checks the current cell volume: if it has not grown
proportional to the time it has lived in this cell cycle, it will become
quiescent because of stress (see below for explanation). Finally, a pro-
liferating cell checks whether it has fulﬁlled the requirements to divide: if
yes, it divides into two cells, if not, it continues to progress through the cell
cycle. The model then repeats the iterations.
Solid stress (38) and increased interstitial ﬂuid pressure (22,39–41) inside
a solid tumor are found to inhibit cell growth in multicellular spheroids and
tumors. To account for the effect external pressure may have on the cell
cycle, we include check points at the end of each phase of the cell cycle to
determine if the cell has increased its volume accordingly. If the cell does not
increase its volume proportional to the time it has spent in that and previous
phases, it will become quiescent due to pressure exerted by the surrounding
tissue. When a cell turns quiescent, it reduces its metabolism and stops its
growth. When a cell dies, it becomes part of the necrotic core (special cell
with ID 0). For a short period of time (24 h) after the cell dies via necrosis,
the cell produces inhibitory factors and some waste.
In spheroid experiments, it has been observed that mitotic cells are
shed from the surface of the spheroid at a constant rate per spheroid
surface—i.e., ;218 cells per square millimeter of spheroid surface per hour
FIGURE 2 Simpliﬁed protein regulatory network for the G1-S phase
transition. The G1 phase consists of six stages (six levels of grayscale).
Avascular Tumor Growth Model 3887
Biophysical Journal 89(6) 3884–3894
for the EMT6 cell line (18,42). In our model, if a proliferating cell is at the
surface of a spheroid of radius.0.03 cm (18), it can shed away with a 20%
shedding probability. Shed cells disappear from further consideration in the
model.
Parameters
Our simulations use parameters derived from spheroids using the mouse
mammary tumor cells, EMT6/Ro. The experimental data for this particular
cell line are abundant (e.g., 8,9,28–30). Although the diffusion coefﬁcients
for oxygen, glucose, and lactate are more readily available in literature
(listed in Table 1), their metabolic rates are harder to come by. We have
derived metabolic rates for oxygen and glucose from different sources
(28,29). Stoichiometrically, every glucose molecule that goes through
anaerobic catabolism by glycolysis generates two lactate molecules. Since
some glucose molecules go through respiratory catabolism instead, we
assumed that on average each glucose molecule consumed results in 1.5
lactate molecules, or the production rate of lactate is 1.5 times the
consumption rate of glucose (see Table 1). The linkage between waste
production and nutrient consumption necessitates that the waste production
rate of quiescent cells is also half that of proliferating cells (28,29).
We have two sets of units in the model: lattice size and Monte Carlo steps
(MCS) in the cellular model, and centimeters and hours in the extracellular
chemical equations. By equating a maximal cell volume in the model to a real
cell size (e.g., 43 43 4 voxels ¼ 1.23 103 mm3), we can convert a lattice
spacing to centimeters. In addition, by equating the duration of the cell cycle
in the model and in real life (e.g., 4 MCS ¼ 12 h), we have the conversion
that oneMCS is equal to 3 h. With these conversions, all physical parameters
can be translated to our model units, and all the model measurements can be
translated into real physical units.
When we convert the metabolic and diffusion parameters to model units,
we take into account the space occupied by extracellular matrix that is
omitted in our cellular model. The lack of data for growth and inhibitory
factors allows us to use relative scale for these factors; we assume that the
medium supplies 100% of required growth factors, and no inhibitory factors
are present outside the spheroid. Consistent with experimental data, we
assume that metabolic rates of quiescent EMT6/Ro cells are approximately
equal to half of that of proliferating cells (28,29).
The diffusion coefﬁcient for oxygen is derived from extensive
microelectrode measurements in spheroids (30,43). The diffusion coef-
ﬁcients for glucose and lactate come from previous experimental deter-
minations on spheroids (44,45). The diffusion coefﬁcients used for the
growth and inhibitory factors were determined by an iterative process to
determine those that gave the best ﬁts to the experimental data. The diffusion
coefﬁcients estimated in this fashion were in the range between 106 and
107 cm2/h.
As the development of the solid tumor is dominated by cell growth
and division, as well as the response to the microenvironment, the simula-
tion results are not sensitive to the differences in cellular adhesion, or the
coupling energy coefﬁcients Jtt9 in Eq. 1, at all. The main effect of the
coupling energy is to keep cells together, rather than morphogenesis due to
TABLE 1 Metabolic rates for nutrients, waste, growth, and inhibitory factors for EMT6/Ro
Oxygen Glucose Waste Growth factors Inhibitory factors
Proliferating cell 108* 162* 240* 1y 0y
Quiescent cell 50* 80* 110* 0.5y 1y
Necrotic 0 0 0 0 2y
Diffusion constant 5.94 3 102z 1.52 3 103z 2.124 3 103z 106z 106z
*The unit is [mM/h/cm3].
yThe unit is [%/h/cm3].
zThe unit is [cm2/h].
FIGURE 3 Flow chart of the model showing the inte-
gration between the intra-, inter-, and extracellular levels.
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differential adhesion. Though no experimental evidence has indicated that
quiescent cells have different cell adhesivity than proliferating ones, we keep
the differential adhesion capability in the model for further model devel-
opment (e.g., including endothelial cells). In all the simulations reported
below, we use the following set of values for the coupling energy coefﬁcient
J: JP,P ¼ JP,Q ¼ 28, JP,N ¼ 24, JP,M ¼ 16, JQ,N ¼ 22, JQ,M ¼ 14, and JN,M ¼
12, where P, Q, N, and M stand for proliferating, quiescent, necrosis, and
medium, respectively. These values could cause cells to ‘‘sort,’’ as in (31).
But because cell sorting due to differential adhesion is a slow process, the
tumor development is dominated by the growth and division of cells as well
as their reaction to the chemical environment. The tumor growth results
would not be different if we used one single value for all coupling co-
efﬁcients.
Volume constraint coefﬁcient g for proliferating cells usually had value
between 1 and 3. To ensure that quiescent cells do not change their volume
easily, once a cell turns quiescent, we set the target volume to its current
volume and increase its volume constraint to four times its current value. As
cells die, their current volumes are added to the necrotic core volume, and
the quiescent and proliferating cells cannot grow against the necrotic region.
In our simulations, oxygen concentration below 0.02 mM, glucose
concentration below 0.06 mM, and lactate concentration above 8 mM
are conditions for cell necrosis. These threshold values are determined in
the following process: we start from the lowest oxygen and glucose con-
centrations used in experiments (e.g., 0.07 mM O2 and 0.8 mM glucose,
from (9)), and tune the threshold values to produce tumor growth that best ﬁt
to the experimental growth curves. Then we use a fraction of the lowest con-
centrations, and further tune the values to produce good growth curves.
RESULTS
Starting fromone single cell, a tumor in our simulations grows
into a spheroidal, layered structure consisting of proliferating
and quiescent cells surrounding a necrotic core. Fig. 4 shows
the cross sections of the same spheroid at different stages of
growth: the initial proliferating cell aggregate; the onset of
quiescence; and the appearance of a necrotic core. The last
cross section is comparable with the experimental picture in
Fig. 1 a.
Fig. 5 shows the growth curves of a solid tumor in
comparison with two sets of experimental data. With 0.08
mM oxygen and 5.5 mM glucose kept constant in the
medium, the number of cells (Fig. 5 a) and the tumor volume
(Fig. 5 b) ﬁrst grow exponentially in time for ;5–7 days.
The growth slows down, coinciding with the appearance of
quiescent cells. In both the experiments and simulations,
spheroid growth saturates after;28–30 days. We ﬁt both the
experimental and the simulation data to a Gompertz func-
tion, y ¼ y0 exp(a(1  exp(bt)), to objectively estimate the
initial doubling times and the spheroid saturation sizes
(8,10). The initial volume and cell number doubling times
for the experiments and the simulation differed by less than
an hour (8.6–9.5 h). The saturation sizes were more different,
with the simulation overestimating the experimental maxi-
mal sizes by factors of 2 (cell number) and 2.5 (spheroid
volume). Given that the simulation covered a range of
spheroid growth of 4–5 orders of magnitude, this agreement
with experiment is excellent.
Experimentally, the fraction of cells in the various cell-
cycle phases was determined by standard ﬂow cytometric
measurement of cellular DNA content as described in detail
previously (9). Solid symbols in Fig. 6 are experimental
measurements of cell-cycle fraction for G1-, S-, and G2-
phases (from (10)). Open symbols are simulation data. We
see in both experimental and simulation data that as the
spheroid radius increases, the fraction of cells in G1-phase
increases, at the same time the fraction of cells in S-phase
drops at a comparable rate. Percent of cells in G2-phase re-
mains roughly constant throughout the spheroid growth. The
simulation data showed an initially high degree of var-
iability, mostly accounted for by the nonrandom distribution
of the initial aggregate and the discrete time sampling in-
volved.
During the development of a layered spheroid structure
the thickness of the viable rim (proliferating and quiescent
cells) remains approximately constant in time (11). In our
simulation, we measured thickness of viable rim of spheroids
by subtracting the necrotic core radius from the radius of
the spheroid. Fig. 7 shows the simulation data for the viable
rim thickness as a function of spheroid size for spheroids
growing in 0.08 mM of oxygen and 5.5 mM of glucose
FIGURE 4 From simulation, cross-sectional view of a spheroid at different stages of development, with cyan, yellow, and magenta correspond to prolif-
erating, quiescent, and necrotic cells. From left to right, 2 days, 10 days, and 18 days of tumor development, respectively, from a single cell.
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medium, where open symbols are simulation data and closed
symbols experimental measurements. The simulation results
agree nicely with experiments in terms of long-term be-
haviors: the necrotic core increases at almost exactly the
same rate as the whole spheroid, while the viable rim size
remains roughly constant. However, our data show an initial
rapid expansion of necrotic core at the onset of necrosis,
which is not present in the EMT6 spheroid data. This rapid
initial onset of necrosis in spheroids has been both predicted
and demonstrated experimentally in other cell systems
(17,46).
To test the robustness of our model, we kept all the param-
eters in the model ﬁxed at the values determined to produce
the best ﬁt to the growth of spheroids in 0.08 mM oxygen
and 5.5 mM glucose. We then varied only the nutrient con-
centrations in the medium, as was done in previous spheroid
experiments. Fig. 8 shows an example of the good agreement
between simulation and experimental growth curves when the
external conditions are changed to 0.28 mMO2 and 16.5 mM
glucose in the medium. Again, ﬁts of the experimental and
simulation data to a Gompertz equation showed good agree-
ment in the initial doubling times and the spheroid saturation
sizes.
DISCUSSION
In our simulations, a single tumor cell evolves into a layered
structure consisting of concentric spheres of proliferating
and quiescent cells at the surface and intermediate layer
respectively, and the necrotic core at the center of the spher-
oid. The spheroid maximum size and the total number of
viable cells depend on the chemical environment provided in
the medium. Our simulations result in a set of conditions for
the cell to undergo necrosis: oxygen concentration below
FIGURE 5 The growth curves of spheroid with 0.08 mM O2 and 5.5 mM
glucose in the medium. (a) The number of cells and (b) the volume of
spheroid in time. The solid diamonds and squares are experimental data for
EMT6/Ro, the circles are simulation results. The solid lines are the best ﬁt
with a Gompertz function (see text) for experimental data.
FIGURE 6 Cell-cycle fraction as a function of time with 0.08 mM O2 and
5.5 mM glucose in the medium. Solid symbols are experimental measure-
ments from the EMT6/Ro cell line; open symbols are the corresponding
simulation. (Red lines indicate G1-phase, black lines indicate S-phase, and
blue lines indicate the G2-phase.)
FIGURE 7 Size of viable rim versus spheroid diameter with 0.08 mM O2
and 5.5 mM glucose in the medium. After initial linear growth, viable rim
thickness reaches approximately constant value. Solid symbols are experi-
mental data from the EMT6/Ro cell line; open symbols are simulation results.
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0.02 mM, glucose concentration below 0.06 mM, and waste
(lactate) concentration above 8 mM. Although it has been
shown that cells can survive these nutrient/waste concen-
trations individually, there are currently no experimental data
available on the effects of combined exposure to these
microenvironmental conditions. These simulation results
suggest that cells are able to survive even in a very nutrient-
deprived environment. These predictions can be tested
experimentally only if chemical concentrations in the
spheroid microenvironment can be systematically measured,
which is difﬁcult using currently-available techniques such
as microelectrodes (30) or bioluminescence (36).
The diffusion coefﬁcients for the growth promoters and
inhibitors are found to be in the order of 107 and 106 cm2/h,
respectively. This diffusion constant range is on the order
of that for peptide growth and inhibitory factors known to
regulate cellular proliferation (e.g., epidermal growth factor,
ﬁbroblast growth factor, tumor necrosis factor, and tumor
growth factor b) based on extrapolation from previous
measurements in spheroids (44). Thus, the model predicts
that cellular proliferation in this system is regulated by
a combination of limited growth promoters and internally
produced growth inhibitors. Interestingly, previous work by
Freyer et al. (12) has shown that a peptide inhibitory factor
was produced by the necrotic regions of spheroids, and that
this inhibitory factor was 80–90 kDa, which would have
a predicted diffusion constant of ;1 3 107 cm2/h in
spheroids.
Our model produces spheroid volume and cell number
growth in remarkable agreement with experimental data
(Figs. 5 and 8). Some adjustment of the simulation param-
eters was performed to optimize this agreement, but the ﬁnal
parameters used in the simulation shown in Fig. 4 are very
close to experimentally measured values, when available.
Importantly, when all parameters were kept constant but the
external concentrations of oxygen and glucose were altered,
the simulation produced growth curves very similar to a
separate set of experiments done under the altered supply
conditions (Fig. 8). This suggests that the underlying model
is accurately representing the dynamic development of the
tumor mass across a wide range of time and distance scales.
The simulation underestimates the number of cells when the
tumor grows to a size comparable to the total lattice size
(Fig. 8). At this point the numerical artifacts in solving the
chemicals result in more accumulation of waste in the tumor,
hence more cell death. This artifact also explains the earlier
tumor growth saturation for the simulation compared to the
experimental data in Fig. 8.
The estimates of cell-cycle fractions as a function of
spheroid growth show good agreement with the experimen-
tal data, especially at large spheroid sizes (Fig. 6). This sug-
gests that the model, and speciﬁcally the protein regulatory
network incorporated therein, is able to predict the regula-
tion of cellular proliferation. The major discrepancy between
the simulation and the experimental data occurs at small
spheroid diameters. This can be explained by the difference
in how these two data sets were generated. The experimental
data represents an average of many (25–100) individual
spheroids, while the simulation shows the values for an
individual spheroid. Thus, the early simulation results are
greatly affected by the cell-cycle stage of the initial cell or
small aggregate. Multiple simulations with different starting
conditions or an initial condition with more cells in random
stages of cell cycle should average to more accurately match
the experimental data.
The simulations of the viable rim thickness indicate
that our model is able to reproduce the experimental data,
especially at spheroid diameters signiﬁcantly larger then
twice the rim thickness. This strongly suggests that necrotic
cell death in spheroids is regulated by a combination of
nutrient depletion and waste accumulation, and that the
progression of necrosis is uncoupled from the regulation of
proliferation (9,10,47). Our simulations, however, show an
FIGURE 8 The growth curves of spheroid with 0.28 mMO2 and 16.5 mM
glucose in the medium: (a) the number of cells and (b) the volume of
spheroid in time. The solid diamonds and squares are experimental data for
EMT6/Ro; open circles are simulation results. The solid lines are the best ﬁt
with a Gompertz function to the experimental data.
Avascular Tumor Growth Model 3891
Biophysical Journal 89(6) 3884–3894
initial rapid growth of the necrotic core, which later slows
down to grow at almost exactly the same rate as the whole
spheroid. The data available for the EMT6 cell line do not
include measurements in the size range at which this rapid
initial expansion is predicted to occur (Fig. 7). However,
very careful experiments with human tumor spheroids have
demonstrated exactly this rapid initial expansion of necrosis
in spheroids (17). Depletion of substrates or accumulation
of waste products has been proposed to be the cause (17).
Detailed analysis of this rapid initial necrosis is underway.
It is somewhat surprising that the simpliﬁed protein regu-
latory network that controls cell-cycle arrest in our model
could produce such a good match to the spheroid data. This
result supports the idea that proliferation arrest is regulated
by the induction of a few speciﬁc proteins, which act pri-
marily in the G1-phase of the cell cycle. The current model
is entirely consistent with the recent work showing that G1-
speciﬁc CKIs are induced, and actively inhibit, their target
CDKs relatively close to the spheroid surface (14). Our
modeling results also suggest that microenvironmental in-
duction of growth arrest is not caused by restrictions on
volumetric expansion of the spheroid. Even though the
model incorporates such a mechanism for cell-cycle arrest,
the results predict that arrest is actually caused by the
induction of G1-phase regulatory proteins. It is important to
note that restricted volumetric growth may be an important
consideration when spheroids, or nodular tumors, are sur-
rounded by a semirigid matrix (38). Our model can be further
reﬁned to include other regulatory pathways, such as S- and
G2-phase arrest, as well as to provide a ﬁner degree of
protein regulation than the on-off Boolean logic used in the
current version. We are investigating whether such reﬁne-
ment can provide a better match of the simulated cell-cycle
distributions and growth curves to the experimental data.
More detailed analysis is possible in our model. For
example, protein expression levels and chemical concen-
trations can be relatively easily obtained from the simu-
lations. Unfortunately, other than for oxygen, there are
currently no experimental data available for comparison with
the chemical composition of the spheroid microenvironment
predicted by our model. In the case of oxygen, we have
obtained concentration gradient proﬁles that are consistent
with previous measurements using microelectrodes in EMT6
spheroids (30), even though the experimental data were ob-
tained on different spheroids at different times. We are also
working on extending the current model past the avascular
stage of tumor growth by incorporating angiogenesis through
a separate protein regulatory network regulated by the micro-
environment.
CONCLUSIONS
We have developed a comprehensive, multiscale cellular
model of avascular tumor growth. On the subcellular level,
we consider a simple protein network that controls transition
between the G1- and S-phases of cell cycle. On the cellular
level, our model uses a lattice Monte Carlo model for cell
dynamics. On the extracellular level, a set of continuous
chemical reaction-diffusion equations describe metabolites,
catabolites, growth factors, and inhibitory factors. The envi-
ronmental parameters we considered were oxygen, glucose,
and lactate concentrations, and relative concentrations of
growth and inhibitory factors. Simulations under different
environmental conditions show both qualitative and quanti-
tative agreement with the experimental data from EMT6/Ro
mouse mammary tumor spheroids. The model predicts the
survival conditions for cells in the microenvironment, and
suggests possible candidates for growth promoters and inhi-
bitors that control cell-cycle arrest.
APPENDIX
The detailed equations for chemicals are
@uO2
@t
¼ DO2=2uO2 1 aðx; y; zÞ;
@un
@t
¼ Dn=2un1 bðx; y; zÞ;
@uw
@t
¼ Dw=2uw1 cðx; y; zÞ;
@ugf
@t
¼ Dgf=2ugf 1 dðx; y; zÞ;
@uif
@t
¼ Dif=2uif 1 eðx; y; zÞ:
In these equations, subscripts O2, n, w, gf, and if stand for oxygen, nutrients,
waste, growth, and inhibitory factors, respectively. D is the diffusion
coefﬁcient. Variables a, b, c, d, and e are consumption and production rates
of these chemicals. Their initial values, ao, b0, and c0 are listed in Table 1.
After we calculate chemical concentrations, we adjust the cells’ con-
sumption rate according to the changed concentrations of oxygen and
glucose,
a ¼ a0
uO2  uTO2
u
O
O2
 uTO2
;
b ¼ b0 un  u
T
n
u
O
n  uTn
;
c ¼ C0 a=a01 b=b0
2
;
where uO is the optimal concentration, and uT is the threshold concentration.
The optimal concentration is 0.28 mM for O2 and is 5.5 mM for glucose. The
threshold concentrations are determined iteratively as described above near
the end of Parameters in Methods (Cellular Model), above. The production
rate of waste is directly proportional to the consumption rates for oxygen and
glucose; therefore, higher consumption corresponds to higher waste pro-
duction. As each cell carries its own consumption rates, which vary accord-
ing to the cell’s state as well as the local chemical ﬁeld, these rates also vary
in space.
The boundary conditions at the tumor medium interface are
uO2 ¼ u0O2 ; un ¼ u
0
n; uw ¼ 0; ugf ¼ 1; uif ¼ 0:
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At time zero, no chemical is present inside the tumor (single cell).
When cells react to the chemical environment, the quiescent cells pro-
duce a small amount of inhibitory factors. During the ﬁrst 24 h after a cell
becomes necrotic, it secretes inhibitory factors at the rate of 0.1 ml/h and
waste at the rate of 10 mM/h.
Since each cell is considered to be chemically homogeneous, the
chemical reaction diffusion equations need to be solved on an irregular
three-dimensional grid with nodes at the center of mass of every cell. We
simplify the matter by coarse-graining the cell lattice by a factor of 4, such
that the grid is still regular and only a few grid points exist inside each cell,
and the concentration within an individual cell is the average of the
concentrations on the grid points within that cell.
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